Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ezetimibe plus simvastatin versus simvastatin alone for progression of carotid artery atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Organon and Co | Conditions: Atherosclerosis, Hypercholesterolemia | Phase 3 | Status: COMPLETED